Hedge Fund - Driehaus Capital
Crinetics Pharmaceuticals Inc. (CRNX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $209,286,313 | 2.02% | 6,239,902 | $37.35 |
| 2 | 2024 - Q4 (2024-12-31) | $313,990,046 | 2.59% | 6,141,014 | $55.95 |
| 3 | 2024 - Q3 (2024-09-30) | $300,736,173 | 2.58% | 5,885,248 | $51.57 |
| 4 | 2024 - Q2 (2024-06-30) | $273,764,229 | 2.64% | 6,112,173 | $46.18 |
| 5 | 2024 - Q1 (2024-03-31) | $244,642,963 | 2.43% | 5,226,297 | $39.13 |
| 6 | 2023 - Q4 (2023-12-31) | $179,321,670 | 2.16% | 5,039,957 | $30.67 |
| 7 | 2023 - Q3 (2023-09-30) | $152,634,215 | 1.98% | 5,132,287 | $20.61 |
| 8 | 2023 - Q2 (2023-06-30) | $95,471,546 | 1.2% | 5,298,088 | $19.94 |
| 9 | 2023 - Q1 (2023-03-31) | $84,949,675 | 1.19% | 5,289,519 | $18.51 |
| 10 | 2022 - Q4 (2022-12-31) | $102,932,815 | 1.53% | 5,624,744 | $17.62 |
| 11 | 2022 - Q3 (2022-09-30) | $110,612,000 | 1.67% | 5,631,958 | $20.39 |
| 12 | 2022 - Q2 (2022-06-30) | $102,099,000 | 1.65% | 5,474,459 | $19.96 |
| 13 | 2022 - Q1 (2022-03-31) | $108,521,000 | 1.33% | 4,944,013 | $20.24 |
| 14 | 2021 - Q4 (2021-12-31) | $136,187,000 | 1.38% | 4,793,638 | $24.65 |
| 15 | 2021 - Q3 (2021-09-30) | $63,119,000 | 0.74% | 2,998,512 | $20.92 |
| 16 | 2021 - Q2 (2021-06-30) | $51,043,000 | 0.67% | 2,707,825 | $17.57 |
| 17 | 2021 - Q1 (2021-03-31) | $30,616,000 | 0.45% | 2,003,688 | $15.50 |
| 18 | 2020 - Q4 (2020-12-31) | $20,515,000 | 0.33% | 1,453,966 | $13.93 |
| 19 | 2020 - Q3 (2020-09-30) | $13,709,000 | 0.28% | 874,842 | $15.29 |
| 20 | 2020 - Q2 (2020-06-30) | $15,536,000 | 0.37% | 886,762 | $17.05 |
The displayed share prices are average quarterly stock market prices.